A prior history of trauma or surgical procedures may be found in the patient' s history 5, 6 . The time that elapses between the bleeding episode (if this is identified at all) and the onset of symptoms varies between months and years. Clinical and surgical treatments of SS-CNS are often ineffective and the disease progresses slowly and inexorably. Although deferiprone 7 and cochlear implants 8 have been tried, a successful form of therapy continues to be sought.
Magnetic resonance imaging (MRI) is essential for confirming the diagnosis of SS-CNS. It shows a characteristic curvilinear pattern of hypointensity on blood-sensitive MRI sequences, reflecting blood residues in the subpial layers of the cerebral cortex or in the subarachnoid space 2 . The magnetic susceptibility effects of blood degradation products are more pronounced at high field strength 2, 6 . It is important to recognize that initial signs of ferritin and hemosiderin deposition can be very subtle and unless the radiologist is well aware of this potential diagnosis, the examination may be reported as being normal 6 . On the other hand, abnormal MRI results may be present in the absence of symptoms of SS 2 . Around 300 cases of SS-CNS have been reported in the literature, mostly as individual case reports or series of three or four cases 9 . The present study presents a series of 13 cases of SS-CNS that occurred in Brazilian patients, thus making this one of the largest series of original cases in the literature.
METHODS
Neurologists from seven academic units in Brazil sent complete clinical and imaging data on patients with the diagnosis of SS-CNS. Both primary and secondary cases of blood products accumulation in the CSN were acceptable for the purpose of this paper.
Only cases with full data were included in the report. All images were analyzed by neuroradiologists according to a strict protocol for acceptance for this series of cases. Reports on the observations were approved by the Ethics Committee. Further approvals from other institutions were obtained whenever required.
Thirteen patients were included in this series (eight men and five women), aged between 38 and 71 years (median age 50 years) at the time of diagnosis.
An MRI was the cornerstone for diagnosing all the cases, and this identified hemosiderin deposition in different areas of the CNS.
RESULTS
The initial symptoms varied, but the most frequent findings were progressive gait ataxia (10 cases), hearing loss (six cases), hyperreflexia ( five cases) and cognitive or behavioral dysfunction ( five cases). All patients presented with progressive onset of signs and symptoms, and received the diagnosis of SS-CNS seven months to 30 years after the disease onset. The episodes leading to accumulation of blood in the CNS of these patients were unidentified in seven cases, brain trauma in two cases, hemorrhagic stroke in two cases and brain surgery in two cases. Whenever the cause for the bleeding was not identified, the patient underwent image examinations for identification of arterial, venous or arterio-venous malformations. No cases of these vascular abnormalities were identified. A summary of all cases is presented in the Table. The Figure shows some characteristic images obtained from these patients.
DISCUSSION
Superficial siderosis of the CNS is a relatively rare condition that needs to be considered in the differential diagnosis for adults presenting with progressive symptoms of dysfunction of the CNS. The presence of previous episodes leading to bleeding into the CNS is helpful while considering SS-CNS as a differential diagnosis of progressive neurological dysfunction, but it is not essential for the diagnosis itself. The signs and symptoms vary, but gait ataxia, hearing loss, hyperreflexia and cognitive dysfunction were the most common findings among the patients of the present series and in previous reports in the literature 9 . The signs and symptoms were progressive in all our patients, in accordance with the physiopathology of SS-CNS.
An MRI is a very important tool for diagnosis, but the medical team needs to be aware of SS-CNS as a potential diagnosis and inform the radiologist of this possibility. The subtle signs of hemosiderin deposition (hypointensity following the contours of the brain and spinal cord) may easily be missed if the radiologist does not have experience with this rare disease 10 . 
